QI LU
LIVE

Serial Number

79282351

Owner

QILU PHARMACEUTICAL CO., LTD.

Attorney

Dana Stewart-Mekdara

Filing Date

Dec 27, 2019

Add to watchlist:

No watchlists yet
View on USPTO

QI LU Trademark

Serial Number: 79282351 • Registration: 6382714

QI LU is a trademark filed by QILU PHARMACEUTICAL CO., LTD. on December 27, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

QILU PHARMACEUTICAL CO., LTD.

No. 317, Xinluo Road,

Entity Type: 99

Trademark Details

Filing Date

December 27, 2019

Registration Date

June 15, 2021

Published for Opposition

March 30, 2021

Goods & Services

Medicines for the prevention and treatment of cancer, nervous system diseases, cardio-cerebrovascular disease, psychiatric disorders, ophthalmic diseases, andrology diseases, all for human purposes; Pharmaceutical preparations for the prevention and treatment of cancer, nervous system diseases, cardio-cerebrovascular disease, psychiatric disorders, ophthalmic diseases, andrology diseases, all for human purposes; Drugs for medical purposes for the prevention and treatment of cancer, nervous system diseases, cardio-cerebrovascular disease, psychiatric disorders, ophthalmic diseases, andrology diseases, all for human purposes; Ointments for pharmaceutical purposes for the prevention and treatment of cancer, nervous system diseases, cardio-cerebrovascular disease, psychiatric disorders, ophthalmic diseases, andrology diseases, all for human purposes; Crude drugs, namely, extracts of hops for pharmaceutical purposes, eucalyptus for pharmaceutical purposes, Mint for pharmaceutical purposes, Malt for pharmaceutical purposes, Pepsins for pharmaceutical purposes, Thymol for pharmaceutical purposes, Turpentine for pharmaceutical purposes, Flaxseed for pharmaceutical purposes, Ferments for pharmaceutical purposes, Cytostatics for pharmaceutical purposes, Balms for pharmaceutical purposes, Digestives for pharmaceutical purposes, Iodine for pharmaceutical purposes, Alcohol for pharmaceutical purposes, and Starch for pharmaceutical purposes, all for the prevention and treatment of cancer, nervous system diseases, cardio-cerebrovascular disease, psychiatric disorders, ophthalmic diseases, andrology diseases, all for human purposes; Cultures of microorganisms for medical or veterinary use; Nutritive substances for microorganisms for medical purposes; Veterinary preparations for pig, farm animals, companion animals, pets, ruminants, namely, vaccine, anti-parasite, antipyretic, analgesic, anti-inflammatory, antibiotic, disinfectants and feed additive preparations; Medicines for veterinary purposes for pig, farm animals, companion animals, pets, ruminants, namely, vaccine, anti-parasite, antipyretic, analgesic, anti-inflammatory, antibiotic, disinfectants and feed additive preparations; antibiotics

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 15, 2026 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 29, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 30, 2021 FICS
FINAL DISPOSITION PROCESSED
Sep 29, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 15, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 15, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 30, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 30, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Mar 28, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 10, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 10, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 10, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 22, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 22, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 22, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 22, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 22, 2021 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 17, 2021 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Feb 16, 2021 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 3, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 3, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 3, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 3, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 3, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 2, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 2, 2021 CRFA
ASSIGNED TO LIE
Feb 1, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 23, 2020 TROA
REFUSAL PROCESSED BY IB
May 15, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 28, 2020 RFCS
REFUSAL PROCESSED BY MPU
Apr 28, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 10, 2020 RFCR
NON-FINAL ACTION WRITTEN
Apr 9, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Apr 7, 2020 MAFR
ASSIGNED TO EXAMINER
Apr 3, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 3, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 2, 2020 REPR